All payments made in the preview are in test mode. Read more
Sign in
Back to Atlas
CTransientStandard research/education caution
CMP-0481
Component of approved clomiphene

Zuclomiphene

Endocrine / SERM

Contributes estrogenic/antiestrogenic effects of clomiphene mixture

Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type
SERM isomer
Primary mechanism
Cis-clomiphene ER modulation with longer persistence
Primary market use
Endocrine research

Pharmacology

Molecular weight (Da)
405.96
Oral bioavailability
Oral as component of clomiphene
Half-life
Long; days-weeks accumulation
Route tags
Route-dependent / verify
Evidence level
Human/Clinical
Clinical status
Component of approved clomiphene
Value-for-money score
3 / 10

Reported protocol signal

No popular protocol verified yet; keep as reference compound until protocol signal is added.

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

Included mainly for isomer clarity; not usually used alone commercially

Educational and organizational assistant matrix. Not medical advice.

BioChrysalis Atlas is an educational, organizational, and tracking asset. It does not provide medical advice, diagnosis, treatment, prescriptions, or individualized dosing instructions. Compound profiles, protocol notes, and dosage fields summarize publicly discussed or source-listed reference patterns and are not recommendations. Consult a qualified healthcare professional before starting, stopping, or modifying any compound, medication, or supplement protocol.

© BioChrysalis · Evolve · Ascend · Transcend